We previously have shown [Takahashi & Kobayashi (1982) Hepatology 2, [249][250][251][252][253][254] that the administration of concanavalin A to mice with schistosomiasis caused liver collagen content to be reduced by 50O . Here we report the effects of concanavalin A and aggregated mouse myeloma IgG on liver lysyl oxidase activity and present further evidence concerning the possible mechanism by which the liver collagen content was decreased in infected-treated mice. The lysyl oxidase activity at 8 weeks after infection in both treated mice and untreated infected controls was about 28-fold greater than in the age-matched uninfected controls. The specific radioactivity of intracellular free [14C]proline, the rate of collagen synthesis, the ratio of collagenase-sensitive, protein-bound, hydroxyproline to proline ofcollagen and the intracellular degradation of newly synthesized collagen were similar in treated animals and in untreated infected controls. In contrast, the extracellular degradation of newly secreted collagen and the specific radioactivity of protein-bound [14C]hydroxyproline in the agent-treated groups were about 2-fold greater than those in the untreated infected controls. These results suggest that the observed 50% decrease in content of liver collagen of mice treated with the agents apparently was due to the increased extracellular degradation of newly secreted collagen.
INTRODUCTION
The collagen content of a tissue is determined by a balance between processes of synthesis and degradation (Harkness et al., 1954) . Newly secreted collagen molecules may be degraded by the priming action of tissue collagenases (EC 3.4.24.7) (Gross & Lapiere, 1962) . The introduction of small amounts of bifunctional cross-links into extracellular collagen may increase resistance to collagenolysis and promote formation of stable fibrils (Vater et at., 1979) .
The pathophysiology of collagen metabolism in fibrotic processes is still largely unknown. We have previously shown that fibrotic livers of mice with schistosomiasis exhibit extremely low collagenase activity and actual amount relative to the rate of collagen synthesis and collagen content (Takahashi & Koda, 1984) . We suggested that this may be the cause of accumulation of collagen (Takahashi et al., 1980) . In other kinds of hepatic fibrosis, the activity of lysyl oxidase, a copper-containing amine oxidase that initiates the formation of lysine-derived cross-links (Pinnell & Martin, 1968a) , is increased (Siegel et al., 1978; Siegel, 1979; Carter et al., 1982) , and this may also contribute to the progressive accumulation of collagen.
In hepatic murine schistosomiasis, the maximal granuloma formation occurring at 8 weeks after infection (Andrade & Warren, 1964) results from a T-lymphocyte-mediated host immune response against soluble egg antigen released by the living schistosome eggs (Boros & Warren, 1970) . The T-lymphocytes and their products appear to regulate the size of granulomas formed in response to the eggs (Colley, 1976; Philips & Colley, 1978; Colley, 1981) . The response to the soluble egg antigen by infected mice can in fact be suppressed by treatment with Con A. That was shown by a 50°% decrease in liver collagen content along with a shift in the peak of collagenase production to 7 weeks from the peak at 8 weeks observed in untreated infected controls; this coincided with the period in which collagen accumulation was maximal (Takahashi & Kobayashi, 1982) . However, the effects of Con A on lysyl oxidase activity, the extent of hydroxylation of proline residues of collagen, the specific radioactivities of [14C]proline or hydroxy[14C]proline of the collagen, and intracellular or extracellular degradation of newly synthesized or secreted collagen in fibrotic livers have not been studied. Recently, simple and sensitive procedures for measurement of various parameters of metabolism of collagen in the tissues have been developed by us. Employing these procedures we quantified the effects of Con A and of aggregated myeloma IgG, known stimulants for the production of mononuclear cell factor (interleukin I) (Dayer et al., 1980) , on liver lysyl oxidase, and studied the possible pathways by which they are able to decrease liver collagen content of mice with schistosomiasis.
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Abbreviations used: Con A, concanavalin A; myeloma IgG, aggregated mouse myeloma IgG; BAPN, fl-aminopropionitrile fumarate; dansyl, 5-dimethylaminonaphthalene-1-sulphonyl; GABA, y-aminobutyric acid; PBS, phosphate-buffered saline (1.5 mM-KH2PO4/2.7 mM-KCI/137 mmNaCl, pH 7.0. (Takahashi & Seifter, 1972) ; the specific activity was 1200 units/mg of protein, without any detectable activity against noncollagenous protein substrates. Other reagents and substrates were the same as described in previous publications (Takahashi et al., 1980; Takahashi & Kobayashi, 1982; Takahashi & Koda, 1984; Takahashi & Biempica, 1985 (Vogt & Dulbecco, 1960) . Animals were killed at 8 weeks after infection with cercariae. Seven mice were used in each group studied. Age-matched normal control mice were also given the same dose of each agent. Preparation of substrate DL-6-[3H]Lysine-labelled type I collagen substrate was prepared from the calvaria of 17-day-old chick embryos as described by Ham & Tanzer (1979) . The SDS/polyacrylamide-gel electrophoretic pattern (Laemmli, 1970) of intact collagen showed a typical type I collagen; this could be digested completely by clostridial collagenase; no solubilized radioactivity was detected when the substrate was allowed to react with trypsin at an enzyme/protein molar ratio of 1: 10 at 37°C for 2-10 h.
The specific radioactivity was 1.8 x 106 d.p.m./nmol of collagen.
Preparation of experimental samples
Livers were perfused with PBS as described by Takahashi & Kobayashi (1982) ; for the study of collagen synthesis, livers were used without perfusion. For the assays, tissue was homogenized (4 ml/g) in 10 mmsodium borate, pH 8.2, containing 4 M-urea. The homogenate was centrifuged at 27000 g for 30 min at 4 IC and the supernatant obtained was saved. The residue was re-extracted with the same volume of buffer for 16 h at 4°C and the extract was combined with the previous one and used for assay. Further extraction with 8 M-urea yielded little lysyl oxidase. Partial purification of liver lysyl oxidase Partial purification ofliver lysyl oxidase was performed by the procedure of Kuivaniemi et al. (1984) and the preparation used for characterization of liver enzyme and for comparative studies of two assay procedures. Enzyme assay Before assay, all samples were dialysed against 500 vol. of assay buffer containing 0.1 % Nonidet P40 for 24 h. The lysyl oxidase activity was measured by two methods. The first method, developed by Pinnell & Martin (1968b) and modified by Ham & Tanzer (1979) , measures the enzymic release of [3H]lysine-labelled collagen substrate in the absence and presence of the inhibitor BAPN (10 gM). Reconstituted collagen substrate (1.8 x 105 d.p.m./0.1 nmol per tube) was used. The recovery controls included a reaction mixture containing no enzyme but known amounts of 3H20. The enzyme activity was expressed as the amount of 3H20 produced/h per mg of DNA or protein.
The second method, developed by Guilbault et al. (1967) for assay of amine oxidase, was adapted by Trackman et al. (1981) for lysyl oxidase. This procedure involves use of diaminopentane as substrate in the absence or presence of the inhibitor, BAPN, and measures the production offluorescence by a homovanillate/peroxidase-coupled reaction. The enzyme activity was expressed as the amount of H202 produced/min per mg of DNA or protein. The assay of partially purified liver lysyl oxidase (0.4-12 ng) by this method was compared with that performed by the first method, and a correlation coefficient (r) of 0.95 was obtained.
Determination of collagen content
The collagen content of a tissue was determined by measuring the content of dansylhydroxyproline and expressed as ,umol (or nmol) of protein-bound hydroxyproline/mg of DNA, as described previously (Takahashi & Biempica, 1985) , with a slight modification. In the present study, dansylhydroxyproline was separated on an octadecyl (C18) column by h.p.l.c. with a modified buffer system based on that of Kaneda et al. (1982) , using a linear gradient of solvent A (0.01 M-Tris/HCl/methanol, 4:1, v/v, pH 7.75) and 33% solvent B (0.01 MTris/HCl/methanol, 1:9, v/v, pH 7.75).
Metabolic labelling
All solutions were sterilized by use of 0.2 gm-pore-size Millipore filters. The labelled proline mixture was purified before use (Berg et al., 1980 At the end of the labelling period, proteinase inhibitors were added to the dishes containing newly synthesized and secreted collagen in the tissue and medium, and contents were sonicated together in 75% ethanol. The sonicated material was centrifuged as described above. The precipitate was washed with 75% ethanol. The supernatant and wash solutions were pooled and freeze-dried. GABA was added to both precipitate and dried sample; these were then hydrolysed, dansylated, and the content of hydroxy(14C]proline in the peak measured by h.p.l.c. [14C] proline in the peak was divided by the amount of unlabelled hydroxyproline or proline in the same peak and expressed as d.p.m./nmol. At the end of the labelling period, proteinase inhibitors were added to the medium, and the tissue and medium were dialysed together and digested with collagenase; GABA was added and the material chromatographed on a Sephadex G-25 column as described above. Fractions containing radioactive peptides and GABA were pooled, hydrolysed, dansylated, and the contents of labelled and unlabelled hydroxyproline and proline measured by h.p.l.c. Collagen degradation
(1) Intracellular degradation of newly synthesized collagen. This was determined by a simplified form of the method of Bienkowski & Engels (1981) . and incubated in chase medium. After 24 h, dishes were removed, proteinase inhibitors and GABA were added, and a 75%-ethanol fraction of the medium was prepared and collected by centrifugation; this was freeze-dried. The material was then dissolved, hydrolysed and dansylated, and the amount of hydroxy[14C]proline in the peak measured by h.p.l.c.
Other methods
The amino acid content was determined by the method of Rosen (1957) , with leucine as standard. The protein content was measured by the method of Bradford (1978) , with bovine serum albumin as standard. The DNA content was determined by the method of Kapuscinski & Skoczylas (1977) , with sonicated calf thymus DNA as standard. Amino acid analyses were performed on a Beckman 120 C amino acid analyser, the single-column methodology of Moore (1963) equipment used was the same as previously reported (Takahashi & Biempica, 1985) . The significance of the data was tested by analysis of variance to determine significant differences between groups; P values of < 0.05 are considered to be significant.
RESULTS AND DISCUSSION
We provide here further evidence concerning the pathway by which liver collagen content is decreased in mice with schistosomiasis treated with certain agents (Takahashi & Kobayashi, 1982) . This decrease apparently is due to increased extracellular degradation of newly secreted collagens. Lysyl oxidase activity was unchanged by the agents used. The procedures used as described below have allowed us to demonstrate this significant observation.
Liver lysyl oxidase
Lysyl oxidase has been extracted from a variety of tissues by a solvent containing 4-6 M-urea or detergent (Siegel, 1979) . In that study the enzyme activity was measured in the presence of 0.1 % Nonidet P40. The release of 3H20 from collagen substrate or the production of H202 from diaminopentane substrate was slightly increased (10 + 3%) in the presence of Nonidet P40, in agreement with the report of Ham & Tanzer (1979) . In many respects the catalytic properties of liver lysyl oxidase are similar to those of lysyl oxidase isolated from other tissues (Siegel, 1979; Trackman & Kagan, 1979) . The partially purified enzyme released 3H20 at a rate of 4.1 x 104 d.p.m./h per mg of protein from native collagen substrate and produced H202 at a rate of 1450 units/min per mg of protein in the diaminopentane/ peroxidase-coupled reaction, and the Michaelis constant (Ki) was 4.7 x 1o-4 M for diaminopentane substrate. The liver lysyl oxidase activity of mice at 8 weeks after infection with Schistosoma mansoni cercariae was similar for animals treated with Con A or myeloma IgG, and untreated infected controls (Table 1) , and was about 28-fold greater than that of the age-matched untreated normal controls (P < 0.001). It should be noted that the partially purified liver lysyl oxidase activity can be inhibited (presumably through a carbohydrate reaction) by preincubation of the enzyme with Con A (100 ,ug/ml) before assay or by the presence of a high concentration of Con A (500-1000 ,ug/ml) in the assay solution.
However, myeloma IgG (60-250 ,ug/ml) had little effect on liver lysyl oxidase activity. Similar results were obtained from livers of infected mice treated with Con A or myeloma IgG, suggesting that the decreased liver collagen content in treated animals, as compared with that of the untreated infected controls, appears not to be attributable to the decreased lysyl oxidase activity.
Metabolic labelling
Recently an improved set of simplified procedures for the measurement of parameters of collagen metabolism was developed by us and is summarized in the Materials and methods section). By using these procedures, the following results were obtained. The intracellular free proline of treated and untreated infected controls was similar and averaged 33. [I4C]proline as described above (Table 2) . This was about 29-fold greater than in the untreated normal controls (P < 0.001). The ratio of collagenase-sensitive, proteinbound hydroxy[14C]proline to [14C] proline was similar in the four groups, averaging 0.83 + 0.01 (mean+ S.E.M., n = 28) and remained constant throughout the incubation (3 h). The specific radioactivities of proteinbound hydroxy[14C]proline were about 2-fold greater in treated groups than in the untreated infected controls and averaged 2.91+0.03 d.p.m./nmol (mean+s.E.M., n = 14) and 1.57+0.01 d.p.m./nmol (mean+S.E.M., n = 14) respectively (P < 0.001). The recovery standard in each group was similar and averaged 76 + 4% . On the other hand, the collagen contents were 2-fold less (Table  2) in treated groups than in the untreated infected controls (P < 0.001); Con A-or myeloma IgG-treated groups did not differ significantly. The synthesis of non-collagenous proteins (d.p.m./h per mg of DNA) was similar among the Con A-treated group (mean 9 130), the myeloma IgG-treated group (mean 9030) and the untreated infected controls (mean 9 300). The recovery of standards for each group was similar and averaged 85 + 7/. The intracellular degradation of newly synthesized collagen was similar among the four groups (about 7.4 + 3%) ( Table 2 ). The extracellular degradation of IgG-treated newly secreted collagen in Con A-or myeloma IgGtreated groups was about 2-fold greater (Table 2) than that of the untreated infected controls (P < 0.001).
Con A-and myeloma IgG-treated groups did not differ significantly.
The specific radioactivity of intracellular free [14C]proline, the rate of collagen synthesis, the ratio of collagenase-sensitive, protein-bound, hydroxyproline to proline of collagen, and the intracellular degradation of newly synthesized collagen and lysyl oxidase activity in treated animals and untreated infected controls were all respectively similar. In contrast, the extracellular degradation of collagen and the specific radioactivities of hydroxy[14C]proline and [14C]proline of collagen in treated groups were about 2-fold greater than those of the untreated infected controls. Thus the decreased collagen content in treated animals appears to result from the increased extracellular degradation of newly secreted collagen. These results agree with our previous observation that collagenase activity and collagenase protein are increased in Con A-treated infected animals relative to untreated infected controls (Takahashi & Koda, 1984) . It should be emphasized that the increased production of collagenase and extracellular degradation of collagen occurred only with fibrotic livers of animals that had been treated with the effective dose of Con A at 5-6 weeks after infection; a similar result was reported previously (Takahashi & Kobayashi, 1982) . These results suggest that the critical effects of the agents used appear to occur at an early developing stage, before the full formation of collagenous extracellular matrix. The agents had no effect, or were less effective, in the later stages of fibrosis (Takahashi & Kobayashi, 1982) . Whether an actual increase in collagenase mRNA occurs in this fibrosis, and no alteration in collagen mRNA occurs in agent-treated animals, remains to be established.
